A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
A Standard patent application filed on 10 January 1996 credited to Franke, Hanshermann
;
Hoffmann, Gerd
;
Cannon, John Burns
;
Arneric, Stephen Peter
;
Sullivan, James Patrick
;
Kindel, Heinrich
Details
Application number :
43911
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
Inventor :
Franke, Hanshermann
;
Hoffmann, Gerd
;
Cannon, John Burns
;
Arneric, Stephen Peter
;
Sullivan, James Patrick
;
Kindel, Heinrich
Agent name :
Davies Collison Cave
Address for service :
GPO Box 3876 SYDNEY NSW 2001
Filing date :
10 January 1996
Associated companies :
Applicant name :
Abbott Laboratories
Applicant address :
100 Abbott Park Road Abbott Park Illinois 60064-3500 United States Of America